Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition

被引：54
|
作者：
Napolitano, M. [1 ]
Megna, M. [2 ]
Fabbrocini, G. [2 ]
Nistico, S. P. [3 ]
Balato, N. [2 ]
Dastoli, S. [3 ]
Patruno, C. [3 ]
机构：
[1] Univ Molise, Dept Med & Hlth Sci Vincenzo Tiberio, Campobasso, Italy
[2] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy
[3] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 181卷 / 03期
关键词：
DRUG ERUPTION; DISEASES;
D O I：
10.1111/bjd.17779
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：604 / 606
页数：3
相关论文
共 50 条
  • [1] Allergic Contact Dermatitis Mimicking Anti-Interleukin 17 Eczematous Eruption
    Casanova-Esquembre, Andres
    Lorca-Sprohnle, Javier
    Labrandero-Hoyos, Carolina
    Penuelas-Leal, Rodrigo
    Zaragoza-Ninet, Violeta
    Perez-Ferriols, Amparo
    DERMATITIS, 2023,
  • [2] Eczematous eruption in patients with psoriasis during risankizumab treatment
    Kromer, Christian
    Schoen, Michael P.
    Moessner, Rotraut
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (05) : 599 - 601
  • [3] Eczematous eruption in patients with psoriasis during risankizumab treatment
    Christian Kromer
    Michael P. Schön
    Rotraut Mössner
    European Journal of Dermatology, 2020, 30 : 599 - 601
  • [4] Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?
    Megna, Matteo
    Caiazzo, Giuseppina
    Parisi, Melania
    Ruggiero, Angelo
    Capasso, Gianmarco
    Mascolo, Massimo
    Russo, Daniela
    Gallo, Lucia
    Fabbrocini, Gabriella
    Napolitano, Maddalena
    Patruno, Cataldo
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (05) : 918 - 925
  • [5] Predicting response to anti-interleukin 12/23 treatment in psoriasis
    Wu, K. C. P.
    Reynolds, N. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (02) : 240 - 241
  • [6] Comment on: 'Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?'
    Li, Mengmeng
    Li, Wei
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (12) : 2306 - 2306
  • [7] Anti-interleukin-17 treatment of psoriasis
    Jinna, Sphoorthi
    Strober, Bruce
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (04) : 311 - 315
  • [8] Effectiveness of anti-interleukin 23 biologic drugs in psoriasis patients who failed anti-interleukin 17 regimens. A real-life experience
    Bonifati, Claudio
    Morrone, Aldo
    Cristaudo, Antonio
    Graceffa, Dario
    DERMATOLOGIC THERAPY, 2021, 34 (01)
  • [9] Author reply to: Comment on: 'Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?'
    Ruggiero, Angelo
    Megna, Matteo
    Caiazzo, Giuseppina
    Parisi, Melania
    Mascolo, Massimo
    Russo, Daniela
    Gallo, Lucia
    Fabbrocini, Gabriella
    Napolitano, Maddalena
    Patruno, Cataldo
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (04) : 396 - 397
  • [10] Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness
    Tsai, Ya-Chu
    Tsai, Tsen-Fang
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2017, 9 (11) : 277 - 294
12345